World's Best Scientists 2026 revealed!
Yuko Kitagawa

Yuko Kitagawa

D-Index & Metrics

Medicine

D-Index
96
Citations
42615
World Ranking
9533
National Ranking
263

Overview

Yuko Kitagawa is a researcher affiliated with Keio University in Japan, with a primary focus in the field of medicine. Their body of work spans major areas including surgery, pulmonary and respiratory medicine, oncology, infectious diseases, and cancer research. Kitagawa's research contribution is notably centered on gastrointestinal cancers and related surgical treatments.

The main topics addressed in Kitagawa's research include:

  • Esophageal Cancer Research and Treatment
  • Gastric Cancer Management and Outcomes
  • Esophageal and GI Pathology
  • Pancreatic and Hepatic Oncology Research
  • Lung Cancer Diagnosis and Treatment
  • Colorectal Cancer Surgical Treatments
  • Gastrointestinal Tumor Research and Treatment

Kitagawa has published extensively in a number of scientific journals, with frequent contributions to:

  • Annals of Surgical Oncology
  • Annals of Gastroenterological Surgery
  • Esophagus
  • Journal of Clinical Oncology
  • Diseases of the Esophagus

Notable recent papers authored by Kitagawa include:

  • Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1, 2023, published in Esophagus

Some of Kitagawa's frequent co-authors are:

  • Satoru Matsuda
  • Hirofumi Kawakubo
  • Hiroya Takeuchi
  • Yoshihiro Kakeji
  • Kazumasa Fukuda

The researcher's work focuses on integrating clinical and surgical approaches in esophageal and gastric cancers, as well as exploring cancer pathology and treatment outcomes. Kitagawa's contributions are part of a broader research effort covering surgery, oncology, and associated health complications in gastrointestinal and respiratory systems.

Best Publications

  • Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

    Ken Kato;Byoung Chul Cho;Masanobu Takahashi;Morihito Okada

  • International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG)

    Donald E. Low;Derek Alderson;Ivan Cecconello;Andrew C. Chang

  • Benchmarking Complications Associated with Esophagectomy.

    Donald E. Low;Madhan Kumar Kuppusamy;Derek Alderson;Ivan Cecconello

  • Mesenchymal stem cells: Mechanisms of immunomodulation and homing.

    Hiroshi Yagi;Alejandro Soto-Gutierrez;Biju Parekkadan;Yuko Kitagawa

  • Improvement in the Results of Surgical Treatment of Advanced Squamous Esophageal Carcinoma During 15 Consecutive Years

    Nobutoshi Ando;Soji Ozawa;Yuko Kitagawa;Yotaro Shinozawa

  • A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database.

    Hiroya Takeuchi;Hiroaki Miyata;Mitsukazu Gotoh;Yuko Kitagawa

  • Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression

    Takashi Seino;Shintaro Kawasaki;Mariko Shimokawa;Hiroki Tamagawa

  • Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1.

    Yuko Kitagawa;Takashi Uno;Tsuneo Oyama;Ken Kato

  • Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society

    Hiroyuki Kuwano;Yasumasa Nishimura;Tsuneo Oyama;Hiroyuki Kato

  • The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.

    Toshirou Nishida;Jean Yves Blay;Seiichi Hirota;Yuko Kitagawa

  • A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy.

    Wataru Kimura;Hiroaki Miyata;Mitsukazu Gotoh;Ichiro Hirai

  • Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2

    Yuko Kitagawa;Takashi Uno;Tsuneo Oyama;Ken Kato

  • Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

    Toshihiro Kudo;Yasuo Hamamoto;Ken Kato;Takashi Ura

  • Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification.

    Yutaka Kurebayashi;Hidenori Ojima;Hanako Tsujikawa;Naoto Kubota

  • The role of the sentinel lymph node in gastrointestinal cancer.

    Yuko Kitagawa;Hirofumi Fujii;Makio Mukai;Tetsuro Kubota

  • Sentinel Node Mapping for Gastric Cancer: A Prospective Multicenter Trial in Japan

    Yuko Kitagawa;Hiroya Takeuchi;Yu Takagi;Shoji Natsugoe

  • Radio-guided sentinel node detection for gastric cancer

    Y Kitagawa;H Fujii;M Mukai;T Kubota

  • Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study).

    Kenichi Nakamura;Ken Kato;Hiroyasu Igaki;Yoshinori Ito

  • Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis

    Kosaku Nanki;Kohta Toshimitsu;Ai Takano;Masayuki Fujii

  • Guidelines for diagnosis and treatment of carcinoma of the esophagus

    Hiroyuki Kuwano;Yasumasa Nishimura;Atsushi Ohtsu;Hiroyuki Kato

Frequent Co-Authors

Masaki Kitajima
Masaki Kitajima Keio University
Satoru Matsuda
Satoru Matsuda Keio University
Michiie Sakamoto
Michiie Sakamoto Keio University
Yuichiro Doki
Yuichiro Doki Osaka University
Hideo Baba
Hideo Baba Kumamoto University
Takanori Kanai
Takanori Kanai Keio University
Hideyuki Saya
Hideyuki Saya Fujita Health University
Toshifumi Hibi
Toshifumi Hibi Kitasato University
Atsushi Ohtsu
Atsushi Ohtsu Juntendo University
Ikuro Maruyama
Ikuro Maruyama Kagoshima University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternatives to traditional medical school can open a wide range of healthcare career opportunities. Many students consider cahme accredited online mha programs list to pursue leadership roles in healthcare management—a path perfect for those looking to make a broad impact on patient care systems rather than providing direct patient care.

For registered nurses aiming to expand their qualifications, pursuing a bachelor’s through an rn to bsn online with no clinicals program offers improved flexibility and less disruption to your current work schedule. Meanwhile, those seeking advanced clinical or leadership roles may benefit from enrolling in dnp online programs, which provide the highest level of nursing education.

If you want to streamline your academic journey, there are also online dnp programs without dissertation that cater to working professionals who desire career growth with less academic research required. These online options make it easier than ever to advance your healthcare career on your terms.

Best Scientists Citing Yuko Kitagawa

Trending Scientists

Recently Published Articles